BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 31889370)

  • 41. Physcion 8-O-β-glucopyranoside induces mitochondria-dependent apoptosis of human oral squamous cell carcinoma cells via suppressing survivin expression.
    Liu MD; Xiong SJ; Tan F; Liu Y
    Acta Pharmacol Sin; 2016 May; 37(5):687-97. PubMed ID: 27063218
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Paraoxonase 3 promotes cell proliferation and metastasis by PI3K/Akt in oral squamous cell carcinoma.
    Zhu L; Shen Y; Sun W
    Biomed Pharmacother; 2017 Jan; 85():712-717. PubMed ID: 27923688
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Spindle and kinetochore-associated complex 3 promotes cell growth via the PI3K/AKT/GSK3β and PI3K/AKT/FOXO1 pathways and is a potential prognostic biomarker for oral squamous cell carcinoma.
    Xu H; Chen G; Niu Q; Song K; Feng Z; Han Z
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2022 Nov; 134(5):599-614. PubMed ID: 36123287
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Function of miR‑152 as tumor suppressor in oral squamous cell carcinoma cells by targeting c‑MET.
    Li M; Li Z; Wang X; Wang Y; Zhao C; Wang L
    Oncol Rep; 2018 Mar; 39(3):1173-1180. PubMed ID: 29286169
    [TBL] [Abstract][Full Text] [Related]  

  • 45. TRIB3 promotes the growth of oral squamous cell carcinoma by regulating JNK/JUN-mediated aerobic glycolysis.
    Meng Z; Wang Y; Wang X; Han X
    Arch Oral Biol; 2024 Aug; 164():105977. PubMed ID: 38696945
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oxysophocarpine Retards the Growth and Metastasis of Oral Squamous Cell Carcinoma by Targeting the Nrf2/HO-1 Axis.
    Liu R; Peng J; Wang H; Li L; Wen X; Tan Y; Zhang L; Wan H; Chen F; Nie X
    Cell Physiol Biochem; 2018; 49(5):1717-1733. PubMed ID: 30231242
    [TBL] [Abstract][Full Text] [Related]  

  • 47. DKK3 Overexpression Increases the Malignant Properties of Head and Neck Squamous Cell Carcinoma Cells.
    Katase N; Nishimatsu SI; Yamauchi A; Yamamura M; Terada K; Itadani M; Okada N; Hassan NMM; Nagatsuka H; Ikeda T; Nohno T; Fujita S
    Oncol Res; 2018 Jan; 26(1):45-58. PubMed ID: 28470144
    [TBL] [Abstract][Full Text] [Related]  

  • 48. LncRNA PART1 promotes cell proliferation and inhibits apoptosis of oral squamous cell carcinoma by blocking EZH2 degradation.
    Yu Q; Du Y; Wang S; Zheng X
    J Biochem; 2021 Sep; 169(6):721-730. PubMed ID: 33725092
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of NLRP3 inflammasome in 5-fluorouracil resistance of oral squamous cell carcinoma.
    Feng X; Luo Q; Zhang H; Wang H; Chen W; Meng G; Chen F
    J Exp Clin Cancer Res; 2017 Jun; 36(1):81. PubMed ID: 28637493
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Increased LGALS3BP promotes proliferation and migration of oral squamous cell carcinoma via PI3K/AKT pathway.
    Zhang X; Ding H; Lu Z; Ding L; Song Y; Jing Y; Hu Q; Dong Y; Ni Y
    Cell Signal; 2019 Nov; 63():109359. PubMed ID: 31302247
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Downregulation of FAP suppresses cell proliferation and metastasis through PTEN/PI3K/AKT and Ras-ERK signaling in oral squamous cell carcinoma.
    Wang H; Wu Q; Liu Z; Luo X; Fan Y; Liu Y; Zhang Y; Hua S; Fu Q; Zhao M; Chen Y; Fang W; Lv X
    Cell Death Dis; 2014 Apr; 5(4):e1155. PubMed ID: 24722280
    [TBL] [Abstract][Full Text] [Related]  

  • 52. LncRNA MEG3 suppresses migration and promotes apoptosis by sponging miR-548d-3p to modulate JAK-STAT pathway in oral squamous cell carcinoma.
    Tan J; Xiang L; Xu G
    IUBMB Life; 2019 Jul; 71(7):882-890. PubMed ID: 30809930
    [TBL] [Abstract][Full Text] [Related]  

  • 53. p12CDK2-AP1 interacts with CD82 to regulate the proliferation and survival of human oral squamous cell carcinoma cells.
    Chai J; Ju J; Zhang SW; Shen ZY; Liang L; Yang XM; Ma C; Ni QW; Sun MY
    Oncol Rep; 2016 Aug; 36(2):737-44. PubMed ID: 27349208
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The antitumor effects of herbal medicine Triphala on oral cancer by inactivating PI3K/Akt signaling pathway: based on the network pharmacology, molecular docking, in vitro and in vivo experimental validation.
    Hu S; Li S; Xu Y; Huang X; Mai Z; Chen Y; Xiao H; Ning W; Gaus S; Savkovic V; Lethaus B; Zimmerer R; Acharya A; Ziebolz D; Schmalz G; Huang S; Zhao J; Hu X
    Phytomedicine; 2024 Jun; 128():155488. PubMed ID: 38493718
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Down-regulation of Akt by methanol extracts of Impatiens balsamina L. promotes apoptosis in human oral squamous cell carcinoma cell lines.
    Shin JA; Ryu MH; Kwon KH; Choi B; Cho SD
    J Oral Pathol Med; 2015 Jul; 44(6):420-8. PubMed ID: 25212570
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of the PI3K/AKT Pathway Sensitizes Oral Squamous Cell Carcinoma Cells to Anthracycline-Based Chemotherapy In Vitro.
    Smolensky D; Rathore K; Bourn J; Cekanova M
    J Cell Biochem; 2017 Sep; 118(9):2615-2624. PubMed ID: 27649518
    [TBL] [Abstract][Full Text] [Related]  

  • 57. LINC00961 suppresses cell proliferation and induces cell apoptosis in oral squamous cell carcinoma.
    Pan LN; Sun YR
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3358-3365. PubMed ID: 31081090
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The role of p21-activated kinase 4 in the progression of oral squamous cell carcinoma by targeting PI3K-AKT signaling pathway.
    Zhang L; Lin S; Zhang Z; Yan C; Liu F
    Clin Transl Oncol; 2023 Mar; 25(3):739-747. PubMed ID: 36593383
    [TBL] [Abstract][Full Text] [Related]  

  • 59. FKBP11 promotes cell proliferation and tumorigenesis via p53-related pathways in oral squamous cell carcinoma.
    Qiu L; Liu H; Wang S; Dai XH; Shang JW; Lian XL; Wang GH; Zhang J
    Biochem Biophys Res Commun; 2021 Jun; 559():183-190. PubMed ID: 33945996
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibition of miR-103a-3p suppresses the proliferation in oral squamous cell carcinoma cells via targeting RCAN1.
    Zhang G; Chen Z; Zhang Y; Li T; Bao Y; Zhang S
    Neoplasma; 2020 May; 67(3):461-472. PubMed ID: 32122140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.